Stem cell shot for frailty? small study tests safety and promise
NCT ID NCT07449364
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single infusion of donor stem cells is safe and could help reduce frailty in older adults aged 60 to 85. Ten participants received the cells and were monitored for six months. Researchers checked for side effects, frailty levels, quality of life, and changes in blood markers of inflammation and immunity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY IN OLDER ADULTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Army Hospital Gatot Soebroto
Jakarta Pusat, Jakarta Special Capital Region, 10410, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple frailty test predict who will have complications after surgery?
- Singapore study aims to keep seniors active and Frailty-Free
- Study tracks frailty after surgery to predict who lives longer
- Hidden drug risk in seniors: common meds linked to confusion and falls
- Stem cells aim to reverse frailty in the elderly